ArticleMedicine2026
Exploratory Mendelian randomization analysis: The genetic susceptibility of CT examination preference and the risk of hypertrophic cardiomyopathy.
Article in Medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Hypertrophic cardiomyopathy (HCM) is a common hereditary heart disease, characterized by myocardial hypertrophy, reduced ventricular cavity, and abnormal myocardial fiber structure. Computed tomography (CT) is a commonly used imaging tool in the diagnosis and risk assessment of cardiovascular diseases. This study aims to conduct an exploratory Mendelian randomization (MR) analysis to investigate the genetic association between the propensity to undergo CT (inferred from genetic variations) and the risk of hypertrophic cardiomyopathy (HCM). In this study, a two-sample MR method was employed. Using the genotype data from the MRC-IEU and FinnGen databases, single-nucleotide polymorphisms related to the phenotype "receiving CT scan" were selected. This phenotype was used as a tool variable for the propensity of CT scan. The CT scan propensity based on genetic prediction was regarded as the exposure factor, and HCM was regarded as the outcome. The associations were estimated using inverse-variance weighting, MR-Egger, and weighted median methods. Additionally, multiplicity tests and leave-one-out analysis were conducted to evaluate the robustness of the tool variable and the stability of the estimated values. In the MR analysis, the inverse-variance weighting method indicated a negative correlation (OR = 2.22 × 10-16, P = .013). However, the MR-Egger and weighted median methods yielded non-significant estimates with wide confidence intervals, reflecting differences in the sensitivity of different analysis methods to potential biases and leading to inconsistent results across methods. The funnel plot and leave-one-out analysis suggested that the set of instrumental variables included in this analysis was statistically robust. This exploratory MR analysis, using a two-sample framework, investigated the genetic relationship between the propensity for undergoing CT scans and the risk of hypertrophic cardiomyopathy. The differences in the estimated values obtained from different analytical methods indicate the inherent complexity involved in using broad non-biological exposure indicators in such studies. These findings are at an early stage and emphasize the importance of using more precise phenotypic definitions in future research to further explore this potential association.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.